Background
Zika virus (ZIKV) is an arbovirus from the Flaviviridae family that was originally described in Uganda during 1947.
1, 2 Although ZIKV is predominantly transmitted by Aedes spp. mosquitos, interhuman transmission has been documented through the parenteral, perinatal, and sexual routes. [3] [4] [5] [6] After the identification of ZIKV, small outbreaks and isolated cases of a self-limited fever have been attributed to ZIKV infection throughout Africa, with specific episodes in Uganda (1969, 1970) , Nigeria (1971 Nigeria ( , 1975 , Sierra Leone (1972) , Gabon (1975) , Central African Republic (1979) , Senegal (1988 Senegal ( , 1991 , and Cote d'Ivoire (1999) . During the 1970s, ZIKV reached southern Asia, where it has been described in Malaysia, Pakistan, and Indonesia (1977) (1978) , as well as in Micronesia (2007) and Cambodia (2010). [7] [8] [9] [10] [11] [12] [13] The clinical signs and symptoms of ZIKV infection include fever, rash, headache, conjunctival hyperemia, myalgia, and joint pain. These signs and symptoms usually last for 3-7 days and then spontaneously resolve. However, serological evidence indicates that up to 80% of infected people do not report any clinical symptoms. 14 ZIKV was first observed in Brazil during 2014, and was likely passed through Polynesia from Asia. The first reports described the virus in the Brazilian states of Bahia and São Paulo, although the virus rapidly spread to the states of Rio de Janeiro, Alagoas, Rio Grande do Norte, Pará, and Maranhão. This rapid spread was likely related to these states being infested with Aedes aegypti. 7, [15] [16] [17] [18] Interestingly, despite only causing self-limited benign disease in Africa, ZIKV infection in some parts of Asia (Micronesia) and Brazil is associated with life-threatening conditions, such as Guillain-Barre syndrome. For example, at least 48 cases of Guillain-Barre syndrome during 2015 in the state of Bahia may have been related to ZIKV infection, and another 130 cases were described in the state of Pernambuco. 19, 20 The most severe complications of ZIKV infection are fetal microcephaly and severe malformations after maternal infection during pregnancy, and these complications have only recently been described in Brazil and Polynesia (2014-2015) . As >4,000 suspected cases of ZIKV-related microcephaly have been reported to Brazilian health authorities, the World Health Organization (WHO) declared that this situation is a Public Health Emergency of International Concern in February 2016. [20] [21] [22] [23] [24] [25] Although theoretically effective, population-level vector control measures (e.g. eliminating mosquito breeding sites) are difficult to implemented and sustain, and in many instances have failed to control other diseases that are transmitted by the same vector (e.g., dengue and chikungunya fever). Therefore, it is possible that personal protective measures (e.g., mosquito repellents and insecticidetreated nets [ITNs] and clothes) could help prevent ZIKV infection during pregnancy. 18 As there are limited data regarding measures to protect against ZIKV infection, this rapid review aimed to assess the effectiveness, efficacy, and safety of personal protective measures for preventing Aedes spp. mosquito bites and/or related arbovirus infections among pregnant women.
Methods
During March-April 2016, we performed a "rapid review" of the literature; this review format uses accelerated systematic review methods to adapt to the current outbreak. This review evaluated three domains (efficacy, effectiveness and safety) and used a two-phase search strategy to identify studies that evaluated personal protective measures that targeted Aedes spp. bites or related arbovirus infections among pregnant women. For each domain, we initially searched the PubMed, and Embase databases for previous literature reviews and systematic review protocols that were published during the last 10 years. For domains with one or more relevant literature reviews, the reviews were assessed using the A Measurement Tool to Assess Systematic Reviews (AMSTAR) checklist, and were adapted to strengthen their methods, focus the search on specific preventive measures, search additional databases, and update the previous search results. For domains with a relevant review protocol but no relevant literature reviews, the protocol was adapted and implemented for the present review. For domains with no previous reviews or protocols, a primary literature search was performed. The full search strategy for each domain is described in Supplementary File 1.
The population of interest was pregnant women, or teratogenic animal studies if no human results were available. Teratogenic studies evaluate substances and provide general information regarding the effects of prenatal exposure on the pregnant test animal and the developing fetus. These studies typically use pregnant rats, mice, or rabbits (and their offspring) to evaluate reproductive effects, structural abnormalities, and toxicity when the substance has not been tested in humans.
The interventions of interest were defined as personal protective measures that were designed to protect against mosquito bites and infection with related arboviruses. These interventions included clothes and nets that were treated using permethrin or deltametrin, topical repellents (e.g., DEET/N,N-Diethyl-meta-toluamide, icaridin, IR3535, and citriodora), and spatial repellents (e.g., transfluthrin coils, metofluthrin coils, D-allethrin coils, pyrethrin coils, metofluthrin emanators, and transfluthrin emanators). The outcomes of interest were defined as a reduction in mosquito bite frequency and/or symptomatic or asymptomatic dengue, chikungunya, or Zika disease that was confirmed using serological or virological tests. We also evaluated adverse events (including teratogenicity) in the pregnant women and tested animals; control patients and animals were defined as having received a placebo or no treatment.
All reports that were published in English, French, Italian, Portuguese, and Spanish were considered eligible for inclusion. The inclusion criteria are shown in Supplementary File 1. Two independent reviewers screened each title and abstract, and the full texts of potentially relevant articles were retrieved for further evaluation. A third reviewer was consulted to address unresolved disagreements between the reviewers. As there were few reports regarding Zika disease and personal protective measures at the time of our search, we also considered other arboviruses that are transmitted by Aedes spp. mosquitos as proxies for ZIKV (e.g., dengue, chikungunya, and yellow fever). Relevant data from the included studies were extracted using domain-specific Microsoft Excel spreadsheets.
The present review did not evaluate the risk of bias in the individual studies, and did not evaluate the summary measures and synthesis of the results. However, the emerging nature of the Brazilian Zika outbreak and the need for additional information regarding ZIKV infection makes it reasonable to evaluate all potentially eligible studies without excessive exclusion of potentially relevant studies.
Results
Domain #1 -The efficacy of repellents against Aedes spp. mosquito bites We identified one relevant literature review that was published in 2013, 26 and assessed it using the AMSTAR checklist. The review included 26 arm-cage assays, large-room evaluation tests, and field trials. After updating and implementing the original search strategy, we identified two additional studies. 27, 28 The studies aimed to understand the protection time and percent coverage for specific repellents formulations, and efficacy of at least 90% was used to conclude that they provided acceptable protection against Aedes spp. bites. This cut-off was used by most of the assessed studies, although there is no consensus or evidence regarding a correlation between this level of efficacy and the prevention of arbovirus infection.
DEET was considered the standard repellent to protect against mosquito bites. The conventional concentrations of DEET (20-25%) provided an efficacy of approximately 90% for protecting against Aedes spp. bites, and this protection lasted 1-8 h (based on the dosage). Icaridin concentrations of 10-20% typically provided 6-7 h of protection against Aedes spp. bites. However, one study of 20% icaridin revealed that it provided 4 h of complete protection against mosquito bites, although this protection was reduced to 1.5 h when it was combined with ethanol and vanillin. IR3535 concentrations of 7.5-20% provided approximately 6-8 h of protection against Aedes spp. bites. One study evaluated six reports that tested citriodora using the arm-cage assay, although citriodora-based repellents were not effective for protecting against Aedes spp. bites. Domain #2 -The in-field effectiveness of the repellents Two randomized controlled trials (RCTs) assessed the effectiveness of deltamethrin-treated curtains for preventing dengue (which is also transmitted by Aedes spp.), and found that these curtains significantly reduced the prevalence of dengue. 29, 30 Both RCTs compared houses that used insecticidetreated curtains or standard care, and provided moderate-quality evidence ( 30 The authors did not find a significant difference between the control and intervention groups, but did observe that the intervention reduced mosquito populations in neighboring control clusters (the spill-over effect), and that infestation was less common in houses that were closer to the treated houses. In 2013, Pino et al. used 80 mg/m 2 of deltamethrin and evaluated the prevalences of single and multiple dengue infection in humans. 29 The insecticide-treated curtains were associated with a reduction in the numbers of dengue virus infections in one area, intra-domiciliary dengue transmissions, and multiple infections. The authors also found that dengue virus-infected Aedes aegypti females were less common in the intervention homes.
Domain #3 -The safety of the personal protective measures
We included 12 reports that included standard toxicity assessment protocols: 5 studies that included pregnant women [31] [32] [33] [34] [35] and 7 studies that used animals [36] [37] [38] [39] [40] [41] [42] (Tables 6 and 7 , respectively). 43 As studies that include pregnant women can be ethically unfeasible, animal studies with teratogenic protocols 43 were also considered for the safety evaluation.
One RCT of DEET concluded that use during the second and third trimesters was safe (use during the first trimester was not evaluated), did not have any teratogenic effects, and only resulted in skin warmth as a side effect. 32 Similarly, three animal studies revealed that DEET was safe during pregnancy, and did not induce any signs of toxicity or congenital abnormality. 39, 40, 42 No studies tested the safety of icaridin among pregnant women. Two studies of rats and rabbits used the toxicity protocol and did not detect any significant adverse effects in the reproductive, embryonic, or fetal parameters that were evaluated. 37, 38 One WHO report from 2006 evaluated the use of IR3535 and concluded that it was safe for use during pregnancy. 44 No other data regarding IR3535 were available from the PubMed and EMBASE databases. A study of citriodora extract in mice revealed that moderate consumption of Lippia citriodora (as an infusion or tea) appeared to be safe during pregnancy and did not have toxic effects on the embryo's development. 41 Deltamethrin is usually used as an insecticide and pesticide (to protect against scabies and mosquito bites), and one study of rats revealed neurotoxic effects, such as impaired cerebellar development leading to motor skills deficits. 36 Four reports evaluated permethrin use in pregnant women (Table 8) ; two reports were related to permethrin-treated nets, one study evaluated a 4% lotion for scabies, and one study evaluated a 1% lotion for head lice. Both studies of the lotions suggested that topical treatment using permethrin was safe during the second and third trimesters. 34, 35 The two reports regarding ITNs evaluated their ability to protect against malaria. One systematic review of 6 studies found that the ITNs were effective at preventing malaria and decreasing mosquito exposure. 45 The 12 reports regarding the safety of the repellents during pregnancy provided low-tomoderate quality evidence. [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] 45 Although we did not find direct evidence of DEET's safety during the first trimester, one study with moderate-quality evidence indicated that DEET was safe during the second and third trimesters. 32 Icaridin and picaridin are similar substances that were tested in animal models, 37 , 38 but were not tested in pregnant women. Although we could not evaluate the safety and effectiveness of IR3535, this substance was reviewed by the WHO and may be an alternative treatment for pregnant women. 43 Citriodora did not effectively protect against Aedes spp. and was only evaluated in a low-quality study. 41 Nets that were treated using permethrin and deltamethrin were effective for preventing dengue. Among the in vitro and animal model studies, we did not identify any evidence of teratogenic effects that were associated with the substances that we evaluated. Permethrin was tested in an RCT that involved pregnant women, and the findings from that trial indicate that it is safe in that population. 34 
Discussion
This rapid review evaluated data regarding the efficacy, effectiveness, and safety during pregnancy of personal protective measures for preventing Aedes spp. mosquito bites or related arbovirus infections. Our results indicate that several mosquito repellents (i.e., DEET, Icaridin/picaridin, and IR3535) were effective for preventing Aedes spp. bites, although these repellents had not been evaluated in the context of preventing arbovirus infections. Curtains that were treated using permethrin and deltamethrin were also effective in reducing the incidence of dengue. Although we did not find any evidence of teratogenic effects in the in vitro and animal model studies, only DEET and permethrin were tested in RCTs that included pregnant women, and both substances were considered safe. Nevertheless, these repellents and substances are supplied in different concentrations and dosages, and it is important that the user understands how to properly use these substances, in order to maximize their personal protection.
Controlling the population of Aedes spp. mosquitos remains the best measure for protecting against the related arbovirus infections (e.g., yellow fever, dengue fever, chikungunya, and ZIKV infection). Thus, mosquito reproduction and ZIKV spread can be blocked by relatively simple measures, such as eliminating stagnant water (i.e., cleaning houses, empting pots, covering water tanks) and proper waste management and sanitation. However, these measures can be difficult to effectively implement, as the affected countries often have complex political, social, and behavioral environments. Furthermore, the worldwide spread of Aedes aegypti confirms that it is difficult to control this vector and ZIKV infection. Moreover, pregnancy is a short period and individuals' personal efforts to prevent ZIKV infection may be effective during this period. Therefore, empowering women by providing them with personal preventative measures may allow them to be less reliant on their neighbors' and countries' complex behavioral and political decisions.
The present review revealed that DEET and icaridin effectively protected against Aedes bites. For example, Lupi et al. reported that 20% DEET provided the best efficacy (10 h of protection) and that citriodora had lower efficacy, compared to other products. 26 Sorge et al. also reviewed repellent use among children, and reported that 20% IR3535 and 20% icaridin provided 4-6 h of protection against Aedes bites. Sorge et al. also reported that DEET was the only repellent that was confirmed to be safe for use by pregnant woman, although some countries (e.g., Canada) do not recommend using DEET at higher concentrations (30-50%) during pregnancy. 46 Similar to our findings, they concluded that the three most frequently recommended personal protective measures are ITNs, mosquito repellent, and insecticide-treated clothes.
Effectiveness against arbovirus infection was only evaluated in studies of insecticide-treated curtains, which provided moderate-quality evidence and suggested that deltamethrin-treated curtains effectively prevented dengue and mosquito bites. However, as there are no studies that have specifically evaluated ZIKV, evidence from these dengue studies may be useful for developing ZIKVspecific preventative measures. Moreover, women can minimize their contact with insecticide-treated curtains, which might result in fewer toxicity-related events. For example, a 2005 WHO report concluded that pyrethroids could be safely used in insecticide-treated mosquito nets, 44 and that report also emphasized that these substances firmly attached to the fabric and provided effect protection for a period of several days.
Although we used standard systematic review methods, the present rapid review has several limitations that warrant consideration. First, we only searched a limited number of databases, although we were able to evaluate reports that were published in six languages. Second, the studies that we identified did not specifically evaluate the measures' effectiveness against Zika disease, and efficacy was evaluated based on the ability to protect against Aedes spp. bites (the primary vector of ZIKV infection). Third, we did not discover any evidence regarding safety during the first trimester. Nevertheless, given the risks of ZIKV-related microcephaly and Guillain-Barre syndrome, it may be prudent to frequently use mosquito repellants, although this use should be guided by the application instructions for the chosen repellent, in order to avoid issues with toxicity.
Conclusion
Although definitive data are lacking, ITNs and mosquito repellents, such as DEET, icaridin and IR3535, may be considered safe and potentially effective measures to protect against ZIKV infection during pregnancy. Future field testing should be performed to confirm these findings. Downgraded to moderate quality due to the fact that serological assessments were carried out only in a subsample of one of the study sites (Trujillo, Venezuela) ++ : Downgraded to moderate quality due to process of randomization and no masking *: Individuals, statistically non significant difference 
